Summary.-For each of a set of 11 methylcholanthrene-induced sarcomas of BlO mice, we measured the amount of H-2 antigen by absorption of a specific antiserum, and the strength of the tumour-specific transplantation antigen by a transplantation assay, to see whether they are correlated. No obvious correlation was seen. We showed that cell suspensions of tumours taken directly from the animal are contaminated by host cells which make a substantial contribution in H-2 assays. Since this contamination was lost after several passages in vitro, the amount of H-2 on tumour cells was assayed only after such passages.
THAT tumour-specific transplantation antigens are like normal major histocompatibility antigens in several ways has led to speculation that they are similar molecules (reviewed in Lennox and Sikora, 1977) , they both appear on the cell surface, induce transplantation immunity and are antigenically diverse. Two kinds of experiments seem to support the suggested relationship. In one, an inverse relationship is shown between the amount of certain tumour antigens and normal histocompatibility antigens in a set of related tumours (Haywood and McKhann, 1971; Ting and Herberman, 1971; Cikes et al., 1973; Tsakraklides et al., 1974) . In the other, tumour cells are shown to express normal major or minor histocompatibility antigens inappropriate to their haplotype (Martin et al., 1973; Garrido et al., 1976; Martin et al., 1977) .
Apart from the studies of Ffaywood and McKhann, the quantitative relationship between H-2 and TSTA on chemically induced sarcomas has not been extensively studied. There are several reasons for doing so. Tumours can be induced with a wide range of easily measured immunogenicities, and seem to form a set of very closely related tumours. Since Haywood and McKhann had investigated only 5 tumours, 3 of which were not immunogenic, we thought it worthwhile to reexamine the possible relationship of amounts of tumour-specific transplantation antigen (TSTA) and H-2 antigen (hereafter referred to as "H-2") using a larger collection of tumours with a wide range of antigenicities. Moreover, it has recently been shown that host cells infiltrate tumours in the animal (Evans, 1972; Kerbel et al., 1975; Pross and Kerbel, 1976) . Since Haywood and McKhann measured the amount of H-2 on cell suspensions prepared from tumour masses, the effect of contaminating host cells on measurements of H-2 needed investigation.
MATERIALS AND METHODS
Mouse strains and tumnours.-B1O and (Bi0xB1O.BR) Fl mice were derived from breeders supplied by the Laboratory Animal Centre, Carshalton, and maintained in our animal house. Tumours were induced by the s.c. injection of 0 5 mg 3-methylcholanthrene (MC) (Eastman-Kodak) dissolved in 0-2 ml trioctanoin (Eastman-Kodak) into the hind limbs of male or female BiG or B1O.BR mice, Gibco-Biocult) . When the cells had grown about 10-fold to confluence, they were removed from the surface of the flask after washing once with 0-2% EDTA and incubated in 0-25% trypsin in 0-2% EDTA at 37°C for 5 min. The cells were then washed X 3 in tissue-culture medium. Cell viability was assessed by trypan-blue exclusion.
Nomenclature of MC-induced tumours. Each tumour was labelled to indicate the mouse strain of origin, the inducing carcinogen, the mouse number and the passage history tn vivo and in vitro. For example, B1O/MC 6A/9/12 designates Tumour A in The reciprocal of this number was taken as the relative amount of surface antigen. The tumour used as standard (relative amount of antigen=l 0) was B1O/MC 9. Details of this procedure are as previously described (Kohler et al., 1977) .
RESULTS

Contamination of tumour cell suspensions by host cells
We measured the amount of H-2 contributed by host-cell infiltration of the tumour mass to cell suspensions prepared directly from the tumour mass, and after varying numbers of passages in vitro. To do this, BlO or BIO.BR tumours were grown in (BlOx) Fl mice and cell sus-531 pensions prepared from them were assayed for ability to absorb anti-H-2k or anti-H-2b sera. This was done with cell suspensions of tumours from the animal and after various transfers in tissue culture. Absorption of B1O.BR anti-BIO (anti-H-2b) serum with B1O/MC 6A/4 tumour-cell suspensions after varying numbers of passages in vitro is shown in Fig. 1(a) . Cell suspensions of tumours taken directly from the animal and after 24 h in vitro absorb a similar amount of anti-H-2b activity. After 3 passages in vitro the same number of cells absorb about half as much. A similar absorption capacity was seen after 6 passages in vitro. Fig. 1(b LeveCl of1compleitlt baekgr-olllt suobtracted ftotmi antisera cytotoxicity. Immunogenicity of MC-induced Bi0 sarcomas The antigenicity of each tumour was defined in terms of its antigenic ratio, the mean tumour diameter in the controls divided by that in immunized animals at 16 days after challenge. In the Table the antigenic ratios of the collection of tumours from several sets of experiments are shown. While the values for a given tumour may vary, the rank order of the tumours remains roughly the same.
Measurement of H-2 on MC-induced sarcomas
In order to quantitate and compare the amount of H-2b antigens on the 11 different MC-induced sarcomas, we needed to know the reproducibility of our quantitative absorption assay. To find this out we measured the amount of H-2b on 2 tumours (B10/MC 6B/4/4 and BIO/MC 5/4/4) in 3 separate absorption experiments. The antiserum and complement dilutions, 51Cr-labelled target cells and medium were made independently for each experiment. Only the tumour suspensions were prepared in one batch, each portion of cells used for the first tube in the absorption series being counted separately.
It was evident that the relative amount of H-2 on each tumour, compared with either B0 LNC or with each other, was fairly constant from one experiment to another. On the other hand, the number of cells required to absorb 50% of the cytotoxic activity from the diluted antiserum varies as much as 2-fold between experiments. This result indicated that the quantity of H-2 could only be reliably compared and normalized to LNC among suspensions in the same experiment, i.e. with the same serum and complement dilutions.
In a single experiment, we measured the amount of H-2 on a set of 11 different MC-induced sarcomas from B1O mice passed 3 times in vitro. Immunogenicity assays had been previously performed and antigenic ratios calculated for each tumour. The relative amount of H-2b vs the antigenic ratio was plotted, each tumour being represented by a point (Fig. 2) .
Two facts are apparent. The first is that the tumours vary greatly in their degree of immunogenicity. The second is that they vary greatly in the expression of H-2b. For most of the tumours there is no obvious correlation between the amount of H-2b and their degree of immunogenicity. However, the 2 most strongly immunogenic tumours do express relatively little measurable H-2, while the most weakly immunogenic tumour expresses a fair amount. All other weakly immunogenic and the moderately immunogenic tumours express a great range of amounts of H-2b.
DISCUSSION
The antigens that appear on tumour cells are baffling by their diversity. The idea that these antigens are related to another diverse set, the major histocompatibility antigens, is appealing, and various kinds of evidence have been produced in support of it. One of the kinds of antigen discussed in this relationship is the set of tumour-specific transplantation antigens of methyleholanthrene-induced sarcomas of mice. Haywood and McKhann (1971) investigated this relationship with 5 tumours of C3H mice, by assaying them for the amount of H-2 and for their immunogenicity. In fact they showed that 3 of them were non-immunogenic and had much H-2, while the 2 immunogenic ones had less H-2. From this they suggested that there is an inverse relationship between these 2 quantities. The implication was that the two sets of antigens are carried by molecules that are closely enough related to compete for expression on the cell membrane.
Our Fig. 2 ? It is important to consider this question carefully, for we do not have to remove many points from the graph to leave a fairly good inverse relationship between immunogenicity (measured by antigenic ratio) and amount of H-2. In fact, if the data from Tumours 7(A), 8, and 12 are ignored (only 3/ 11 tumours), we could make a good case for this relationship. We can see, however, no justification for doing this. While the absolute amounts of H-2 measured on the various tumours do vary from one experiment to another, their ranking on the basis of amount of H-2 stays fairly constant. The same holds true for the measurements of immunogenicity.
We think that the question whether tumour-associated antigens or tumourspecific transplantation antigens are like major histocompatibility antigens will not be answered by experiments of this kind. An answer will come from these experiments that examine this relationship more directly, either by serological or chemical techniques. In the end only comparison of the isolated molecules can settle this question.
